BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11988362)

  • 1. Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.
    Länge R; Dietrich D
    Toxicol Lett; 2002 May; 131(1-2):97-104. PubMed ID: 11988362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations to address uncertainties in environmental risk assessment using toxicokinetic-toxicodynamic models.
    Baudrot V; Charles S
    Sci Rep; 2019 Aug; 9(1):11432. PubMed ID: 31391484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current uncertainties and challenges of publicly available pharmaceutical environmental risk assessment data.
    Ahkola H; Äystö L; Sikanen T; Riikonen S; Pihlaja T; Kauppi S
    Eur J Pharm Sci; 2024 Jun; 197():106769. PubMed ID: 38631463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the Development of Human Health Toxicity Values for Active Pharmaceutical Ingredients in the Environment.
    Sorell TL
    AAPS J; 2016 Jan; 18(1):92-101. PubMed ID: 26338232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on in silico prediction of the environmental risks posed by pharmaceutical emerging contaminants.
    Gao J; Zhao J; Chen X; Wang J
    Environ Monit Assess; 2023 Nov; 195(12):1535. PubMed ID: 38008816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update to the toxicological profile for water-soluble and sparingly soluble tungsten substances.
    Lemus R; Venezia CF
    Crit Rev Toxicol; 2015 May; 45(5):388-411. PubMed ID: 25695728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved method for toxicological profiling of chemical substances.
    Daniyan MO; Omisore NO; Adeyemi OI; Olusa AS; Olaniran SF; Oyemitan IA; Akanmu MA; Olayiwola G
    Toxicol Mech Methods; 2024 Jun; 34(5):545-562. PubMed ID: 38267361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the relevance of environmental exposure data sets.
    Peters A; Beking M; Oste L; Hamer M; Vuaille J; Harford AJ; Backhaus T; Lofts S; Svendsen C; Peck C
    Integr Environ Assess Manag; 2024 Jul; 20(4):1004-1018. PubMed ID: 38099403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating Modeling Data From Repeat-Dose Toxicity Reports.
    López-Massaguer O; Pinto-Gil K; Sanz F; Amberg A; Anger LT; Stolte M; Ravagli C; Marc P; Pastor M
    Toxicol Sci; 2018 Mar; 162(1):287-300. PubMed ID: 29155963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects?
    Martin OV; Martin S; Kortenkamp A
    Environ Health; 2013 Jul; 12(1):53. PubMed ID: 23816180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Justification for species selection for pharmaceutical toxicity studies.
    Prior H; Haworth R; Labram B; Roberts R; Wolfreys A; Sewell F
    Toxicol Res (Camb); 2020 Dec; 9(6):758-770. PubMed ID: 33442468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects in traditional and alternative toxicity tests.
    Browne P; Paul Friedman K; Boekelheide K; Thomas RS
    Regul Toxicol Pharmacol; 2024 Mar; 148():105579. PubMed ID: 38309424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving beyond Risk Quotients: Advancing Ecological Risk Assessment to Reflect Better, More Robust and Relevant Methods.
    Raimondo S; Forbes VE
    Ecologies (Basel); 2022 May; 3(2):145-160. PubMed ID: 35754780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental Considerations in Cardiovascular Risk Assessment and Prevention.
    Al-Kindi S; Silversides CK
    JACC Adv; 2023 May; 2(3):100361. PubMed ID: 38939596
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology beyond the patient - The environmental risks of human drugs.
    Gunnarsson L; Snape JR; Verbruggen B; Owen SF; Kristiansson E; Margiotta-Casaluci L; Österlund T; Hutchinson K; Leverett D; Marks B; Tyler CR
    Environ Int; 2019 Aug; 129():320-332. PubMed ID: 31150974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards Precision Ecotoxicology: Leveraging Evolutionary Conservation of Pharmaceutical and Personal Care Product Targets to Understand Adverse Outcomes Across Species and Life Stages.
    Brooks BW; van den Berg S; Dreier DA; LaLone CA; Owen SF; Raimondo S; Zhang X
    Environ Toxicol Chem; 2024 Mar; 43(3):526-536. PubMed ID: 37787405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and remediation of pharmaceuticals and pesticides using metal oxides and carbon nanomaterials.
    Fallah Z; Zare EN; Ghomi M; Ahmadijokani F; Amini M; Tajbakhsh M; Arjmand M; Sharma G; Ali H; Ahmad A; Makvandi P; Lichtfouse E; Sillanpää M; Varma RS
    Chemosphere; 2021 Jul; 275():130055. PubMed ID: 33984903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental risk assessment of pharmaceuticals at a seasonal holiday destination in the largest freshwater shallow lake in Central Europe.
    Molnar E; Maasz G; Pirger Z
    Environ Sci Pollut Res Int; 2021 Nov; 28(42):59233-59243. PubMed ID: 32666449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquatic concentrations of chemical analytes compared to ecotoxicity estimates.
    Kostich MS; Flick RW; Batt AL; Mash HE; Boone JS; Furlong ET; Kolpin DW; Glassmeyer ST
    Sci Total Environ; 2017 Feb; 579():1649-1657. PubMed ID: 28040196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocatalysis on the surface of Escherichia coli: melanin pigmentation of the cell exterior.
    Gustavsson M; Hörnström D; Lundh S; Belotserkovsky J; Larsson G
    Sci Rep; 2016 Oct; 6():36117. PubMed ID: 27782179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.